Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde 3 phosphate dehydrogenase pseudogene 49 (GAPDHP49)
- Target
- GAPDHP49
- Molecular classification
- Other (pseudogene; genomic DNA sequence derived from retrotransposition)
01
Overview
Glyceraldehyde 3 phosphate dehydrogenase pseudogene 49 is one of many *processed pseudogenes* derived from the parent GAPDH gene in the human genome[2]. The GAPDH gene encodes a key glycolytic enzyme, but the pseudogenes (including GAPDHP49) are non-coding genomic sequences generated by the retrotransposition of GAPDH mRNA and subsequent integration into new genomic loci[2][3]. These pseudogenes do not encode functional proteins, do not participate in cellular metabolism, and have no documented role in disease pathways or direct involvement in drug targeting[2][3][6]. GAPDHP49 is annotated and catalogued in pseudogene databases and is primarily of interest for studies on genomic evolution and gene duplication events, not for translational or clinical research purposes[2][3].
- Other names
- GAPDHP49glyceraldehyde 3-phosphate dehydrogenase pseudogene 49
02
Mechanism of action
None (pseudogenes have no mechanism of action; GAPDH enzyme-targeting drugs act via glycolysis inhibition or modulation)
03
Biological functions
Other (no known biological function; does not encode a functional protein)
04
Disease associations
Other (none established; pseudogenes like GAPDHP49 do not play direct roles in disease)
05
Safety considerations
None
06
Interacting drugs
None
07
Biomarkers
None
Beyond the preview
Go deeper on Glyceraldehyde 3 phosphate dehydrogenase pseudogene 49 (GAPDHP49).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Glyceraldehyde 3 phosphate dehydrogenase pseudogene 49 (GAPDHP49).